Nu Med Debt To Equity vs. Total Debt
| NUMD Stock | USD 0.01 0 10.00% |
For Nu Med profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nu Med to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nu Med Plus utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nu Med's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nu Med Plus over time as well as its relative position and ranking within its peers.
NUMD |
Nu Med Plus Total Debt vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nu Med's current stock value. Our valuation model uses many indicators to compare Nu Med value to that of its competitors to determine the firm's financial worth. Nu Med Plus is considered to be number one stock in debt to equity category among its peers. It also is rated top company in total debt category among its peers making up about 55,676 of Total Debt per Debt To Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nu Med's earnings, one of the primary drivers of an investment's value.NUMD Total Debt vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Nu Med |
| = | 0.04 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Nu Med |
| = | 2.06 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
NUMD Total Debt vs Competition
Nu Med Plus is rated top company in total debt category among its peers. Total debt of Medical Devices industry is now estimated at about 4.03 Billion. Nu Med adds roughly 2,060 in total debt claiming only tiny portion of all equities under Medical Devices industry.
Nu Med Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nu Med, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nu Med will eventually generate negative long term returns. The profitability progress is the general direction of Nu Med's change in net profit over the period of time. It can combine multiple indicators of Nu Med, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah. Nu Med operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 2 people.
NUMD Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nu Med. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nu Med position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nu Med's important profitability drivers and their relationship over time.
Use Nu Med in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nu Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nu Med will appreciate offsetting losses from the drop in the long position's value.Nu Med Pair Trading
Nu Med Plus Pair Trading Analysis
The ability to find closely correlated positions to Nu Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nu Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nu Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nu Med Plus to buy it.
The correlation of Nu Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nu Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nu Med Plus moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nu Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nu Med position
In addition to having Nu Med in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Funds Thematic Idea Now
Consumer Funds
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in NUMD OTC Stock
To fully project Nu Med's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nu Med Plus at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nu Med's income statement, its balance sheet, and the statement of cash flows.